SPOTLIGHT: Altus hires new CEO


Altus Pharmaceuticals has hired Georges Gemayel from Genzyme to be its new CEO. Gemayel had been executive vice president at Genzyme. Both companies are based in Cambridge. Release

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.